Bactiguard AB: Interim Report For Q2 2016

STOCKHOLM--(BUSINESS WIRE)--Regulatory News:

Bactiguard Holding (STO:BACTIB)

The positive trend with increased sales of our own portfolio of infection prevention products for the healthcare sector has continued and we delivered almost 110 000 units in the quarter. We have delivered a total of approximately 200 000 products so far this year, well above the total annual volume for 2015. License revenues are also back at a stable level in the quarter. Altogether, revenues are higher and costs are lower resulting in a significant improvement in operating profit.

Back to news